Current status on tissue factor activation of factor VIIa

Area of Science:

• Biochemistry
• Molecular Biology
• Hematology

Background:

• Free factor VIIa (FVIIa) exhibits limited intrinsic enzymatic activity, functioning similarly to a zymogen.
• Coagulation initiation requires the formation of a complex between FVIIa and tissue factor (TF).
• TF binding enhances FVIIa's procoagulant activity through membrane localization, substrate exosites, and allosteric activation.

Purpose of the Study:

• To elucidate the allosteric mechanism by which TF binding activates FVIIa.
• To summarize current knowledge on TF-induced conformational changes in FVIIa.
• To highlight the role of specific molecular interactions in FVIIa activation.

Main Methods:

• Review and compilation of existing knowledge on FVIIa-TF interaction.
• Analysis of molecular interactions at the FVIIa-TF interface.
• Focus on the crosstalk between FVIIa's protease domain (Met-306) and TF's N-terminal domain.

Main Results:

• TF binding induces high-affinity interaction, engaging all domains of both factors.
• Specific crosstalk, notably involving FVIIa residue Met-306, initiates allosteric activation.
• TF binding stabilizes the active conformation of FVIIa, enhancing its enzymatic function.

Conclusions:

• TF-mediated allosteric activation is crucial for initiating blood coagulation.
• The precise pathways of TF-induced conformational transitions in FVIIa require further mapping.
• Understanding this mechanism provides insights into coagulation regulation and potential therapeutic targets.